Calls for action on patients denied £100,000 cystic fibrosis drug
This article was taken from: https://www.theguardian.com/science/2019/feb/03/nhs-cystic-fibrosis-drug-orkambi-vertex By Sarah Boseley Health editor Exclusive: Ministers urged to consider revoking patent on life-extending Orkambi, which NHS cannot afford Campaigners are calling on the government to urgently intervene over the cost of a drug that could extend the lives of thousands of children but which manufacturers have set at £105,000 per patient per…